bevacizumab,atezolizumab
roche
['bevacizumab', 'hcc', 'atezo']
adjuvant atezolizumab plus bevacizumab significantly improves rfs in high-risk hcc #aacr2023 #hpbcscm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.